Loading...
Endometriosis And Hair Loss Therapies Will Unlock Long-Term Value Through AI-Driven Biologic Development
AN
AnalystConsensusTarget
Not Invested
Based on Analyst Price Targets
Published
04 Dec 25
Views
82
04 Dec
US$5.09
AnalystConsensusTarget's Fair Value
US$8.11
37.3% undervalued intrinsic discount1Y
91.4%7D
-8.1%1Y
91.4%7D
-8.1%You can edit this narrative until Dec 5 2:05 PM. Then, changes will post as Updates.
Author's Valuation
US$8.1137.3% undervalued intrinsic discount
AnalystConsensusTarget Fair Value